The production of retatrutide, a novel dual stimulant targeting both GLP-1 and GIP receptors, requires a complex multi-step organic process. Initial routes focused on amino acid chain section coupling, utilizing solid-phase synthesis methodologies to build the long peptide sequence. Subsequent investigation has explored various approaches, includin